News

Pharmabiz8h

Clearside Biomedical to explore strategic alternatives to advance its proprietary SCS delivery platform and promising ophthalmology pipeline

Clearside’s innovative SCS Microinjector is being used in commercial ophthalmic products and promising clinical development programs by Aura Biosciences, Bausch + Lomb, BioCryst Pharmaceuticals, ...
Pharmabiz9h

Kenvue collaborates with API to launch India’s first cough clinics to advance symptom science in respiratory primary care

Our Bureau, Mumbai Monday, July 21, 2025, 17:15 Hrs [IST] ...
Pharmabiz9h

Fangzhou & Novo Nordisk sign MoU to establish a new ecosystem for health management

Fangzhou & Novo Nordisk sign MoU to establish a new ecosystem for health management: Beijing Monday, July 21, 2025, 17:00 Hrs [IST] Fangzhou Inc., a leader in Internet healthcare ...
Pharmabiz10h

Sun Pharma announces positive results from phase 3 clinical studies evaluating tildrakizumab 100 mg in active psoriatic arthritis

Our Bureau, Mumbai Monday, July 21, 2025, 16:30 Hrs [IST] ...
Pharmabiz10h

Venus Foundation inks 5-year MoU with Haryana govt to transform government schools into future-ready learning hubs

Our Bureau, Bengaluru Monday, July 21, 2025, 16:20 Hrs [IST] ...
Pharmabiz10h

Jagat Pharma relaunches Isotine Eye Gummy for kids with an improved formulation and a new flavour

Jagat Pharma relaunches Isotine Eye Gummy for kids with an improved formulation and a new flavour: Our Bureau, Mumbai Monday, July 21, 2025, 16:10 Hrs [IST] Jagat Pharma, a truste ...
Pharmabiz10h

Saluda Medical announces full US launch of EVA sensing technology for use with the Evoke SmartLoop System

Saluda Medical announces full US launch of EVA sensing technology for use with the Evoke SmartLoop System: Minneapolis Monday, July 21, 2025, 16:00 Hrs [IST] Saluda Medical, Inc., ...
Pharmabiz11h

NIMHANS strengthens early detection and management of neuro disorders with KaBHI

NIMHANS strengthens early detection and management of neuro disorders with KaBHI: Our Bureau, Bengaluru Monday, July 21, 2025, 15:40 Hrs [IST] National Institute of Mental Health ...
Pharmabiz12h

UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK

UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK: Hørsholm, Denmark Monday, July 21, 2025, 14:00 Hrs [IST] ALK, a global specia ...
Pharmabiz13h

10x Genomics & A*STAR GIS launch TISHUMAP study to advance AI-driven drug target discovery

Genomics & A*STAR GIS launch TISHUMAP study to advance AI-driven drug target discovery: Pleasanton, California Monday, July 21, 2025, 13:00 Hrs [IST] 10x Genomics, Inc., a lea ...
Pharmabiz14h

US FDA grants orphan drug designation to ImCheck’s ICT01 for treatment of acute myeloid leukaemia

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...
Pharmabiz15h

Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint

Viatris announces phase 3 study of MR-139 for blepharitis fails to meet its primary endpoint: Pittsburgh Monday, July 21, 2025, 11:00 Hrs [IST] Viatris Inc., a global healthcare c ...